biotech
biotech Articles
Shares of FibroGen saw a handy gain on Wednesday after the biopharmaceutical company announced the pricing of its underwritten follow-on offering.
Published:
Shanghai-based biopharmaceutical company Zai Lab has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a recent initial public offering that could come blessed with magical upside if its possibilities blossom into a positive reality. The company is...
Published:
Last Updated:
The July 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
When FibroGen released its most recent quarterly results after the markets closed on Monday, its was not the most important news that broke.
Published:
Last Updated:
Here are four biotech stocks for which the team of analysts at Jefferies, and analysts at other firms, see big upside potential from upcoming near-term drug study catalysts.
Published:
Last Updated:
Although Agile Therapeutics stock is down year to date, it’s actually more or less doubled since January. So now might be the time to take some profit.
Published:
Last Updated:
Zealand Pharma intends to price nearly 4 million shares at a price that will result in an initial public offering valued up to almost $98 million.
Published:
Last Updated:
AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
Tetraphase Pharmaceuticals saw its shares pull back on Friday after the company announced that it has priced a secondary offering.
Published:
Last Updated:
After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. Here are four big opportunities for aggressive...
Published:
Last Updated:
The July 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Gilead Sciences, Inc. (NASDAQ: GILD) shares basically remained unchanged after the firm announced an approval from the U.S. Food and Drug Administration (FDA). Essentially, the FDA approved Vosevi...
Published:
Last Updated:
Puma Biotechnology, Inc. (NASDAQ: PBYI) saw its shares touch a multiyear high on Tuesday after the firm reported a key approval by the U.S. Food and Drug Administration (FDA). Specifically, the...
Published:
Last Updated:
Sienna Biopharmaceuticals filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company expects to price its 4.33 million shares...
Published:
Last Updated: